Search

everythinglearnresearchcommunity

for

Search:↓

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

TikTok videos show that people with Lupus often discuss symptoms and their significant impact on mental health, face diagnostic delays, have mixed views on treatments, and feel isolated despite support.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Lupus patients on TikTok feel isolated, face medical gaslighting, and prefer non-drug treatments.

The MPV/PC ratio can help assess disease activity in alopecia areata.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

The conclusion is that high-potency steroids or tacrolimus are effective treatments for erosive pustular dermatosis of the scalp.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Looking at skin can help find and treat serious diseases early.

Steroids are the best treatment for Alopecia Areata with few side effects.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Hydroxychloroquine may help treat alopecia areata in children.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Aging in men is influenced by genetics and lifestyle, leading to muscle loss, bone issues, and skin damage.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Hair transplantation can successfully treat stubborn alopecia areata.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.